Assess Safety and Efficacy of VAD044 in HHT Patients

Clinical trial NCT05406362 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05406362
Sponsor: Vaderis Therapeutics AG
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hereditary Hemorrhagic Telangiectasia (HHT)

Start date: 2022-07-18
Primary completion: 2027-01-01
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.